Drug Profile
Research programme: carnitine O-palmitoyltransferase inhibitors - DARA BioSciences
Alternative Names: DB200; VX100Latest Information Update: 17 Feb 2012
Price :
$50
*
At a glance
- Originator Valexx Pharmaceuticals
- Developer Fortovia Therapeutics
- Class Small molecules
- Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Suspended Psoriasis
Most Recent Events
- 15 Feb 2012 Research programme: carnitine O-palmitoyltransferase inhibitors - DARA BioSciences is available for licensing as of 15 Feb 2012. http://www.darabio.com
- 02 Jul 2008 Preclinical development is ongoing
- 27 Jul 2007 Preclinical trials in Psoriasis in USA (Topical)